Effect of vitamin C on inflammation and metabolic markers in hypertensive and/or diabetic obese adults: A randomized controlled trial

Drug Design, Development and Therapy

Volumn 9, Issue , 2015, Pages 3405-3412

  Ellulu, Mohammed S ^a   Rahmat, Asmah ^a   Patimah, Ismail ^b   Khaza’Ai, Huzwah ^b   Abed, Yehia ^c  

^a Department of nutrition and Dietetics ^*  (Malaysia)

^b UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^c AL QUDS UNIVERSITY   (Palestine)

Author keywords

Adiposity; Anti inflammatory; Diabetes; Hypertension; Obesity; Vitamin C

Indexed keywords

ASCORBIC ACID; C REACTIVE PROTEIN; GLUCOSE; INTERLEUKIN 6; TRIACYLGLYCEROL; ANTIINFECTIVE AGENT; AUTACOID; BIOLOGICAL MARKER; CHOLESTEROL; GLUCOSE BLOOD LEVEL; IL6 PROTEIN, HUMAN;

ADULT; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DRUG EFFECT; FEMALE; HUMAN; HYPERTENSION; INFLAMMATION; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; OBESITY; OPEN STUDY; PALESTINE; PRIMARY HEALTH CARE; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; WAIST CIRCUMFERENCE; BLOOD; DIABETES MELLITUS, TYPE 2; DRUG ADMINISTRATION; DRUG EFFECTS; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; ORAL DRUG ADMINISTRATION; TIME FACTOR; TREATMENT OUTCOME; YOUNG ADULT;

ADMINISTRATION, ORAL; ADULT; ANTI-INFECTIVE AGENTS; ASCORBIC ACID; BIOMARKERS; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYPERTENSION; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MALE; MIDDLE AGED; OBESITY; TIME FACTORS; TREATMENT OUTCOME; TRIGLYCERIDES; YOUNG ADULT;

EID: 84936866559     PISSN: None     EISSN: 11778881     Source Type: Journal    
DOI: 10.2147/DDDT.S83144     Document Type: Article

References (40)

1. Wilson JX. Regulation of vitamin C transport. Annu Rev Nutr. 2005;25:105–125.
2. Afkhami-Ardekani M, Vahidi AR, Borjian L, Borjian L. Effect of vitamin C supplement on glycosylated hemoglobin in patients with type 2 diabetes. J Shah Sad Univ. 2003;10:15–18.
3. Plantinga Y, Ghiadoni L, Magagna A, et al. Supplementation with vitamins C and E improves arterial stiffness and endothelial function in essential hypertensive patients. Am J Hypertens. 2007;20(4):392–397.
4. Salonen RM, Nyyssönen K, Kaikkonen J, et al; Antioxidant Supplementation in Atherosclerosis Prevention Study. Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: the Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study. Circulation. 2003;107(7):947–953.
5. Myint PK, Luben RN, Welch AA, Bingham SA, Wareham NJ, Khaw KT. Plasma vitamin C concentrations predict risk of incident stroke over 10 y in 20 649 participants of the European Prospective Investigation into Cancer Norfolk prospective population study. Am J Clin Nutr. 2008;87(1):64–69.
6. Duffy SJ, Gokce N, Holbrook M, et al. Treatment of hypertension with ascorbic acid. Lancet. 1999;354(9195):2048–2049.
7. Jariyapongskul A, Rungjaroen T, Kasetsuwan N, Patumraj S, Seki J, Niimi H. Long-term effects of oral vitamin C supplementation on the endothelial dysfunction in the iris microvessels of diabetic rats. Microvasc Res. 2007;74(1):32–38.
8. Siavash M, Amini M. Vitamin C may have similar beneficial effects to Gemfibrozil on serum high-density lipoprotein-cholesterol in type 2 diabetic patients. J Res Pharm Pract. 2014;3(3):77–82.
9. Gaur GS, Dixit AK. Comparative study of vitamin C on serum lipid profile in healthy male and female human subjects. J Sci Res. 2012; 4(3):775–781.
10. Montero D, Walther G, Stehouwer A, Houben A, Beckman J, Vinet A. Effect of antioxidant vitamin supplementation on endothelial function in type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. Obes Rev. 2014;15(2):107–116.
11. Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008;454(7203):428–435.
12. Boura-Halfon S, Zick Y. Phosphorylation of IRS proteins, insulin action, and insulin resistance. Am J Physiol. 2009;296(4):E581–E591.
13. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 1993;259(5091):87–91.
14. Emanuela F, Grazia M, Marco de R, Maria Paola L, Giorgio F, Marco B. Inflammation as a Link between Obesity and Metabolic Syndrome. J Nutr Metab. 2012;2012:476380.
15. Zhang S, Liu Q, Wang J, Harnish DC. Suppression of interleukin-6-induced C-reactive protein expression by FXR agonists. Biochem Biophys Res Commun. 2009;379(2):476–479.
16. Ford ES, Liu S, Mannino DM, Giles WH, Smith SJ. C-reactive protein concentration and concentrations of blood vitamins, carotenoids, and selenium among United States adults. Eur J Clin Nutr. 2003;57(9):1157–1163.
17. Mikirova N, Casciari J, Riordan N, Hunninghake R. Clinical experience with intravenous administration of ascorbic acid: achievable levels in blood for different states of inflammation and disease in cancer patients. J Transl Med. 2013;11:191.
18. Du J, Cullen JJ, Buettner GR. Ascorbic acid: chemistry, biology and the treatment of cancer. Biochim Biophys Acta. 2012;1826(2):443–457.
19. Aditi A, Graham DY. Vitamin C, gastritis, and gastric disease: a historical review and update. Dig Dis Sci. 2012;57(10):2504–2515.
20. Sexton P, Black P, Metcalf P, et al. Influence of mediterranean diet on asthma symptoms, lung function, and systemic inflammation: a randomized controlled trial. J Asthma. 2013;50(1):75–81.
21. Jialal I, Singh U. Is vitamin C an antiinflammatory agent? Am J Clin Nutr. 2006;83(3):525–526.
22. World Health Organization (WHO) Department of Non-communicable Diseases. Global Physical Activity Questionnaire: Analysis Guide. Geneva: WHO; 2002. Available from: http://www.who.int/chp/steps/resources/GPAQ_Analysis_Guide.pdf. Accessed May 26, 2015.
23. Block G, Jensen C, Dietrich M, Norkus E, Hudes M, Packer L. Plasma C-reactive protein concentrations in active and passive smokers: influence of antioxidant supplementation. J Am Coll Nutr. 2004;23(2):141–147.
24. Centers for Disease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System Survey Questionnaire. Atlanta, GA: US Department of Health and Human Services CDC; 2011.
25. WHO. Obesity: Preventing and Managing the Global Epidemic: Report of a WHO Consultation. WHO Technical Report Series 894. Geneva: WHO; 2000. Available from: http://www.who.int/nutrition/publications/obesity/WHO_TRS_894/en/. Accessed May 26, 2015.
26. National Institute for Health and Clinical Excellence. Obesity: The Prevention, Identification, Assessment and Management of Overweight and Obesity in Adults and Children. London: National Institute for Health and Clinical Excellence; 2006.
27. Cárcamo JM, Bórquez-Ojeda O, Golde DW. Vitamin C inhibits granulocyte macrophage-colony-stimulating factors-induced signaling pathway. Blood. 2002;99(9):3205–3212.
28. Choi JS, Choi YJ, Park SH, Kang JS, Kang YH. Flavones mitigate tumor necrosis factor-alpha-induced adhesion molecule upregulation in cultured human endothelial cells: role of nuclear factor-kappa B. J Nutr. 2004;134(5):1013–1019.
29. Wu X, Schauss AG. Mitigation of inflammation with foods. J Agric Food Chem. 2012;60(27):6703–6717.
30. Jang IS, Ko YH, Moon YS, Sohn SH. Effects of Vitamin C or E on the Pro-inflammatory Cytokines, Heat Shock Protein 70 and Antioxidant Status in Broiler Chicks under Summer Conditions. Asian-Australas J Anim Sci. 2014;27(5):749–756.
31. Peluso I, Villano D, Roberts S, et al. Consumption of mixed fruit-juice drink and vitamin C reduces postprandial stress induced by a high fat meal in healthy overweight subjects. Curr Pharm Des. 2014;20(6): 1020–1024.
32. Zhang KY, Li YH, Cheng XY, et al. Cross-over study of influence of oral vitamin C supplementation on inflammatory status in maintenance hemodialysis patients. BMC Nephrol. 2013;14:252.
33. Block G, Jensen C, Dalvi T, et al. Vitamin C treatment reduces elevated C-reactive protein. Free Radic Biol Med. 2009;46(1):70–77.
34. Wannamethee SG, Bruckdorfer KR, Shaper AG, Papacosta O, Lennon L, Whincup PH. Plasma vitamin C, but not vitamin E, is associated with reduced risk of heart failure in older men. Circ Heart Fail. 2013;6(4):647–54.
35. Wannamethee SG, Lowe G, Rumley A, Bruckdorfer KR, Whincup PH. Associations of vitamin C status, fruit and vegetable intakes, and markers of inflammation and hemostasis. Am J Clin Nutr. 2006;83(3):567–574; quiz 726–727.
36. Aguiló A, Monjo M, Moreno C, Martinez P, Martínez S, Tauler P. Vitamin C supplementation does not influence plasma and blood mononuclear cell IL-6 and IL-10 levels after exercise. J Sports Sci. 2014;32(7):1659–1669.
37. Khajehnasiri F, Mortazavi SB, Allameh A, Akhondzadeh S. Effect of omega-3 and ascorbic acid on inflammation markers in depressed shift workers in Shahid Tondgoyan Oil Refinery, Iran: a randomized double-blind placebo-controlled study. J Clin Biochem Nutr. 2013;53(1):36–40.
38. Afkhami-Ardekani M, Shojaoddiny-Ardekani A. Effect of vitamin C on blood glucose, serum lipids and serum insulin in type 2 diabetes patients. Indian J Med Res. 2006;126:471–474.
39. Sargeant LA, Wareham NJ, Bingham S, et al. Vitamin C and hyperglycemia in the European Prospective Investigation into Cancer – Norfolk (EPIC-Norfolk) study: a population-based study. Diabetes Care. 2000;23(6):726–732.
40. Dakhale GN, Chaudhari HV, Shrivastava M. Supplementation of vitamin C reduces blood glucose and improves glycosylated hemoglobin in type 2 diabetes mellitus: a randomized, double-blind study. Adv Pharmacol Sci. 2011;2011:195271.